John E. Imhoff - 21 Aug 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role
Director, 10%+ Owner
Signature
/s/ John E. Imhoff
Issuer symbol
GTHP
Transactions as of
21 Aug 2025
Transactions value $
$30,000
Form type
4
Filing time
05 Sep 2025, 16:16:44 UTC
Previous filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Imhoff John E Director, 10%+ Owner 5853 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS /s/ John E. Imhoff 04 Sep 2025 0001348439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHP Common Stock Other +104K +0.58% 18.1M 21 Aug 2025 Direct F1
transaction GTHP Preferred Series E Stock Other -300 -75% 100 21 Aug 2025 Direct F2
transaction GTHP Common Stock Other +1.2M +6.63% 19.3M 21 Aug 2025 Direct F2
transaction GTHP Common Stock Purchase $30K +167K +0.86% $0.18 19.5M 29 Aug 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHP Warrants Purchase +167K +666.67% 192K 29 Aug 2025 Common Stock 167K $0.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.
F2 On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.
F3 On August 29, 2025, the Company entered into a Securities Purchase Agreement with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $30,000, 166,667 units, each unit consisting of one share of common stock and one warrant to purchase up to 166,667 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.25 per share.